LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

Search

Neogen Corp

Slēgts

SektorsVeselības aprūpe

5.56 -6.08

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

5.45

Max

5.95

Galvenie mērījumi

By Trading Economics

Ienākumi

649M

36M

Pārdošana

-16M

209M

P/E

Sektora vidējais

657.5

106.172

EPS

0.05

Peļņas marža

17.371

Darbinieki

2,974

EBITDA

667M

89M

Rekomendācijas

By TipRanks

Rekomendācijas

Neitrāls

Prognoze 12 mēnešiem

+38.01% upside

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

172M

1.4B

Iepriekšējā atvēršanas cena

11.64

Iepriekšējā slēgšanas cena

5.56

Ziņu noskaņojums

By Acuity

27%

73%

60 / 374 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Strong Bullish Evidence

Neogen Corp Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 19. nov. 23:36 UTC

Karstas akcijas

Stocks to Watch: Nvidia, Kulicke & Soffa, Regeneron

2025. g. 19. nov. 22:13 UTC

Peļņas
Iegādes, apvienošanās, pārņemšana

Palo Alto Networks to Buy Chronosphere for $3.35 Billion, Posts Higher 1Q Revenue -- Update

2025. g. 19. nov. 21:55 UTC

Galvenie tirgus virzītāji

Amgen Lung Cancer Drug Gets Full Approval From FDA

2025. g. 19. nov. 21:43 UTC

Iegādes, apvienošanās, pārņemšana

Palo Alto Networks to Buy Chronosphere for $3.35 Billion

2025. g. 19. nov. 23:55 UTC

Tirgus saruna

Gold Rises on Possible Investment Demand -- Market Talk

2025. g. 19. nov. 23:54 UTC

Tirgus saruna

BHP Vicuna JV Offers Significant Copper Output, At a Cost -- Market Talk

2025. g. 19. nov. 23:47 UTC

Peļņas

Lenovo Group 2Q EPS $2.52 >0992.HK

2025. g. 19. nov. 23:46 UTC

Peļņas

Lenovo Group: Delivered Double-Digit Yr-on-Yr Rev Growth Across All Main Business Groups and Sales Geographies >0992.HK

2025. g. 19. nov. 23:45 UTC

Peļņas

Lenovo Group 2Q Rev $20.5B >0992.HK

2025. g. 19. nov. 23:42 UTC

Tirgus saruna

Nikkei May Rise After Nvidia's Strong Earnings Soothe Investors' Nerves -- Market Talk

2025. g. 19. nov. 23:42 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 19. nov. 23:41 UTC

Peļņas

Lenovo Group 2Q Adj Net $512.0M Vs. $409.0M >0992.HK

2025. g. 19. nov. 23:41 UTC

Peļņas

Lenovo Group 2Q Net $340.0M Vs. Net $359.0M >0992.HK

2025. g. 19. nov. 23:40 UTC

Peļņas

Lenovo Group 2Q Rev $20.45B Vs. $17.85B >0992.HK

2025. g. 19. nov. 22:55 UTC

Peļņas

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- 4th Update

2025. g. 19. nov. 22:41 UTC

Peļņas

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- 3rd Update

2025. g. 19. nov. 22:30 UTC

Iegādes, apvienošanās, pārņemšana

CICC Seeks Trading Halt in Hong Kong, Shanghai Stock Exchange

2025. g. 19. nov. 22:30 UTC

Peļņas

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- 2nd Update

2025. g. 19. nov. 22:30 UTC

Iegādes, apvienošanās, pārņemšana

CICC Plans to Acquire Brokerage Firms via Share-Swap Agreement

2025. g. 19. nov. 22:27 UTC

Iegādes, apvienošanās, pārņemšana

China International Capital Plans to Acquire Brokerage Firms Cinda Securities, Dongxing Securities

2025. g. 19. nov. 22:08 UTC

Peļņas

ZTO Express (Cayman) 3Q Rev $1.67B >ZTO

2025. g. 19. nov. 22:00 UTC

Peļņas

Investors Cheer Blockbuster Nvidia Earnings -- WSJ

2025. g. 19. nov. 21:58 UTC

Peļņas
Iegādes, apvienošanās, pārņemšana

Palo Alto Networks to Buy Chronosphere for $3.35B, Posts Higher 1Q Rev -- Update

2025. g. 19. nov. 21:52 UTC

Peļņas

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- Update

2025. g. 19. nov. 21:50 UTC

Tirgus saruna
Peļņas

Tech, Media & Telecom Roundup: Market Talk

2025. g. 19. nov. 21:49 UTC

Tirgus saruna
Peļņas

Nvidia Quiets Investor Fears With Ballooning Demand -- Market Talk

2025. g. 19. nov. 21:38 UTC

Peļņas

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- WSJ

2025. g. 19. nov. 21:28 UTC

Iegādes, apvienošanās, pārņemšana

Palo Alto Networks to Buy Chronosphere for $3.35B

2025. g. 19. nov. 21:27 UTC

Iegādes, apvienošanās, pārņemšana

Exact Sciences Stock Jumps on Reported Deal Interest from Abbott Laboratories -- Barrons.com

2025. g. 19. nov. 21:24 UTC

Peļņas
Iegādes, apvienošanās, pārņemšana

Palo Alto Networks 1Q Next-Generation Security ARR $5.9 B >PANW

Salīdzinājums

Cenas izmaiņa

Neogen Corp Prognoze

Cenas mērķis

By TipRanks

38.01% augšup

Prognoze 12 mēnešiem

Vidējais 8.17 USD  38.01%

Augstākais 10 USD

Zemākais 6.5 USD

Pamatojoties uz 4 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Neogen Corp — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Neitrāls

4 ratings

1

Pirkt

3

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

5.17 / 5.99Atbalsts un pretestība

Īstermiņā

Strong Bullish Evidence

Vidējā termiņā

Weak Bearish Evidence

Ilgtermiņā

Weak Bearish Evidence

Noskaņojums

By Acuity

60 / 374 Rangs Veselības aprūpe

Ziņu noskaņojums

Liecība "Buļļu" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Virs vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Neogen Corp

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns, as well as food quality and nutritional components. It also provides AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared food products and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. The company was incorporated in 1981 and is headquartered in Lansing, Michigan.
help-icon Live chat